Ironman Registry (Prostate Cancer)

Purpose of this Study

We are doing this study to learn more about prostate cancer and whether certain treatments are related with different outcomes and patient experiences.

Who Can Participate?

Eligibility

Adult patients who have advanced prostate cancer

What is Involved?

If you choose to join this study, you will:<ul>
<li>Have your cancer-related experiences tracked as you undergo standard treatment for your prostate cancer</li>
<li>Answer questions about your treatment and experience every three months for two years then every six months for a minimum of three years</li>
<li>Have blood samples that will be collected before study entry, at each treatment change, after 1 year of participation, and after 2 years of participation</li></ul>

Study Details

Full Title

IRONMAN: International Registry for Men with Advanced Prostate Cancer

Principal Investigator

Daniel
George

Protocol Number

PRO00080554

NCT ID

NCT03151629

Phase

N/A

Enrollment Status

Open to Enrollment